Lipocine Stock News

State Street Corp increased its holdings in Lipocine Inc. (NASDAQ:LPCN) by 2,356.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 304,617 shares of the specialty pharmaceutical companys stock after acquiring an additional 292,217 shares during the period. State Street []

Sesen Bio (NASDAQ:SESN) and Lipocine (NASDAQ:LPCN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Profitability This table compares Sesen Bio and Lipocine’s net margins, return on equity and return on […]

Lipocine Inc. (NASDAQ:LPCN) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 5.41% to the previous days close as strong demand from buyers drove the stock to $1.17. Actively observing the price movement in the last trading, the stock closed the session at $1.11, falling within a range of $1.09 and Looking For A Top Momentum Stock? Why Lipocine Inc. (NASDAQ: LPCN) Is A Great Pick Read More »

LPL Financial LLC boosted its position in Lipocine Inc. (NASDAQ:LPCN) by 46.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 62,750 shares of the specialty pharmaceutical companys stock after purchasing an additional 20,000 shares during the quarter. LPL Financial LLC owned about 0.07% of []

Geode Capital Management LLC grew its holdings in shares of Lipocine Inc. (NASDAQ:LPCN) by 26.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 760,586 shares of the specialty pharmaceutical companys stock after purchasing an additional 156,873 shares during the quarter. []

Equities research analysts expect Lipocine Inc. (NASDAQ:LPCN) to announce earnings of ($0.05) per share for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Lipocines earnings. The lowest EPS estimate is ($0.06) and the highest is ($0.04). Lipocine posted earnings per share of ($0.06) in the same quarter last year, which indicates []

Lipocine has obtained positive results in a phase 2 study using its drug LPCN1144 for the treatment of patients with NASH.

Looking for penny stocks on Reddit? Check these 5 out The post Penny Stocks to Buy Now?

Lipocine Inc (NASDAQ: LPCN) has entered into an exclusive licensing agreement with Antares Pharma Inc (NASDAQ: ATRS) to commercialize Tlando in the U.S.  Tlando is an oral testosterone product f

A jump in penny stock prices has retail traders cashing out on big gains. The post Penny Stocks To Watch Today As Buying Drives ADMP, IO, LPCN & Others appeared first on Penny Stocks to Buy, Picks, Ne

SALT LAKE CITY, Oct. 18, 2021 /PRNewswire/ -- Under the terms of Agreement Lipocine to receive: Up to $21.0 million in licensing fees, including $11.0 million payable immediately and $10.0 million to

SALT LAKE CITY, Oct. 5, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company wi

Are these 3 Reddit penny stocks on your watchlist right now? The post Top Reddit Penny Stocks to Watch in September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

Penny stocks with high marks from analysts right now. The post Top Penny Stocks Analysts Say To Buy, Targets Up To 200% Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | P

Lipocine Inc (NASDAQ: LPCN) has announced topline 36-week results from its Phase 2 proof of concept LiFT study investigating LPCN 1144 in Non-Alcoholic Steatohepatitis (NASH). LPCN 1144 comprises